Press Releases Prescient Therapeutics Limited

Equities

Delayed Australian S.E. Other stock markets 09:36:14 2024-05-06 pm EDT			5-day change	1st Jan Change
0.046 ^AUD	0.00%		-11.54%	-25.81%

Mar. 25	Transcript : Prescient Therapeutics Limited - Special Call
Feb. 23	Prescient Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Prescient Therapeutics showcases cell therapy data at prestigious ISCT conference	23-06-16	AQ
Prescient Therapeutics thrilled with additional Orphan Drug Designation status for PTX-100	23-03-09	AQ
Prescient Therapeutics : June 2022 Quarterly Update and Appendix 4C	22-07-24	PU
Prescient Therapeutics : Application for quotation of securities - PTX	22-07-21	PU
Prescient Therapeutics : Application for quotation of securities - PTX	22-06-15	PU
Prescient Therapeutics : March 2022 Quarterly Update and Appendix 4C	22-04-28	PU
Prescient Therapeutics : Application for quotation of securities - PTX	22-04-06	PU
Prescient Therapeutics : Application for quotation of securities - PTX	21-12-06	PU
Prescient Therapeutics : Application for quotation of securities - PTX	21-11-29	PU
Prescient Therapeutics : March 2019 Appendix 4C - Quarterly	19-04-24	PU
Prescient Therapeutics : Notice of General Meeting/Proxy Form	19-03-27	PU
Prescient Therapeutics : Amended Appendix 3B - Rights Issue	19-03-27	PU
Prescient Therapeutics : Letter to Optionholders	19-03-24	PU
Prescient Therapeutics : Letter to Ineligible Shareholders	19-03-24	PU
Prescient Therapeutics : Letter to Eligible Shareholders	19-03-24	PU
Prescient Therapeutics : Appendix 3B - Rights Issue	19-03-24	PU
Prescient Therapeutics : Prospectus	19-03-24	PU
Prescient Therapeutics : Capital Raising Presentation - March 2019	19-03-24	PU
Prescient Therapeutics : Completes Equity Raising to Raise $9.1 Million	19-03-24	PU
Prescient Therapeutics : Investor Presentation - February 2019	19-02-24	PU

No results for this search